Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma.

Zhang Y, Zhang T, Zhao Y, Wu H, Zhen Q, Zhu S, Hou S

Open source

DOI
10.1186/s12885-023-11221-6
Published
2023 Aug 16
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-023-11221-6,
  title = {Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma.},
  author = {Zhang Y and Zhang T and Zhao Y and Wu H and Zhen Q and Zhu S and Hou S},
  year = {2023},
  journal = {BMC cancer},
  doi = {10.1186/s12885-023-11221-6},
  url = {https://doi.org/10.1186/s12885-023-11221-6}
}

RIS

TY  - JOUR
TI  - Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma.
AU  - Zhang Y
AU  - Zhang T
AU  - Zhao Y
AU  - Wu H
AU  - Zhen Q
AU  - Zhu S
AU  - Hou S
PY  - 2023
JO  - BMC cancer
DO  - 10.1186/s12885-023-11221-6
UR  - https://doi.org/10.1186/s12885-023-11221-6
ER  - 

APA

Y, Z., T, Z., Y, Z., H, W., Q, Z., S, Z., & S, H. (2023). Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma.. BMC cancer. https://doi.org/10.1186/s12885-023-11221-6

Source records